Compare Duolingo Inc (DUOL) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Duolingo Inc vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Duolingo Inc trades at $138.01 (market cap $6.54B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.61B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is the larger of the two by market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Duolingo Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Duolingo Inc for 138 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| DUOL | RDY | |
|---|---|---|
Market Cap | $6.54B | $10.61B |
Volume | 985,128 | 3,738,869 |
Sector | Technology | Health |
52-Week High | $341.08 | $15.38 |
52-Week Low | $90.03 | $11.38 |
Typical Hold Time | 138 Days | 0 Days |
Enterprise Value | $5.31B | $10.51B |
Dividend Yield | — | 0.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Duolingo (DUOL) trades at $140.1, down 5.17% over the past day, amid mixed technical signals but strong fundamental performance. The stock shows a bullish moving average trend and neutral oscillators, with key support near $143. Financially, the company reported robust revenue growth, reaching $1.04 billion in 2025, with a net income margin of 35.87% and consistent earnings beats in recent quarters. Recent news highlights CEO share sales and AI-driven growth initiatives, contributing to investor attention.
The outlook for DUOL remains positive given its earnings momentum and expanding user base, though risks include insider selling and competitive pressures. Analyst consensus leans bullish with a $142.50 price target, suggesting modest upside from current levels, supported by institutional interest and solid cash flow generation.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Duolingo Inc
Duolingo Inc is a mobile learning platform to learn languages and the top-grossing app in the Education category on both Google Play and the Apple App Store. It has three predominant sources of revenue
Read more on DUOL →About Dr. Reddy's Laboratories Ltd Common Stock
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →
